Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Cook

Showing results (111-120 of 158) with videos related to

Pageof 16
Sort By:
British Journal of Haematology|February 3, 2009
Bortezomib, low-dose intravenous melphalan, and dexamethasone for patients with relapsed multiple myelomaRakesh Popat, Heather Oakervee, Catherine Williams, et al.
Eclinicalmedicine|May 13, 2020
Anti-seizure therapy with a long-term, implanted intra-cerebroventricular delivery system for drug-resistant epilepsy: A first-in-man studyMark Cook, Michael Murphy, Kristian Bulluss, et al.
Blood Cancer Journal|April 2, 2022
Ixazomib with cyclophosphamide and dexamethasone in relapsed or refractory myeloma: MUKeight phase II randomised controlled trial resultsHolger W Auner, Sarah R Brown, Katrina Walker, et al.
Journal of Neural Engineering|September 2, 2017
Intracranial EEG fluctuates over months after implanting electrodes in human brainHoameng Ung, Steven N Baldassano, Hank Bink, et al.
Journal of the American Society of Nephrology : JASN|April 23, 2011
Early reduction of serum-free light chains associates with renal recovery in myeloma kidneyColin A Hutchison, Paul Cockwell, Stephanie Stringer, et al.
Ebiomedicine|December 22, 2017
Epileptic Seizure Prediction Using Big Data and Deep Learning: Toward a Mobile SystemIsabell Kiral-Kornek, Subhrajit Roy, Ewan Nurse, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 3, 2009
Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysisColin A Hutchison, Arthur R Bradwell, Mark Cook, et al.
Epilepsy & Behavior : E&B|August 27, 2021
Long-term mood, quality of life, and seizure freedom in intracranial EEG epilepsy surgeryOshi Swarup, Alexandra Waxmann, Jocelyn Chu, et al.
The Lancet. Haematology|March 16, 2019
High cutoff versus high-flux haemodialysis for myeloma cast nephropathy in patients receiving bortezomib-based chemotherapy (EuLITE): a phase 2 randomised controlled trialColin A Hutchison, Paul Cockwell, Veronica Moroz, et al.
Annals of Clinical and Translational Neurology|February 23, 2018
Is seizure frequency variance a predictable quantity?Daniel M Goldenholz, Shira R Goldenholz, Robert Moss, et al.
Pageof 16

Showing results (111-120 of 158) with videos related to

Sort By:
Pageof 16
British Journal of Haematology|February 3, 2009
Bortezomib, low-dose intravenous melphalan, and dexamethasone for patients with relapsed multiple myelomaRakesh Popat, Heather Oakervee, Catherine Williams, et al.
Eclinicalmedicine|May 13, 2020
Anti-seizure therapy with a long-term, implanted intra-cerebroventricular delivery system for drug-resistant epilepsy: A first-in-man studyMark Cook, Michael Murphy, Kristian Bulluss, et al.
Blood Cancer Journal|April 2, 2022
Ixazomib with cyclophosphamide and dexamethasone in relapsed or refractory myeloma: MUKeight phase II randomised controlled trial resultsHolger W Auner, Sarah R Brown, Katrina Walker, et al.
Journal of Neural Engineering|September 2, 2017
Intracranial EEG fluctuates over months after implanting electrodes in human brainHoameng Ung, Steven N Baldassano, Hank Bink, et al.
Journal of the American Society of Nephrology : JASN|April 23, 2011
Early reduction of serum-free light chains associates with renal recovery in myeloma kidneyColin A Hutchison, Paul Cockwell, Stephanie Stringer, et al.
Ebiomedicine|December 22, 2017
Epileptic Seizure Prediction Using Big Data and Deep Learning: Toward a Mobile SystemIsabell Kiral-Kornek, Subhrajit Roy, Ewan Nurse, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 3, 2009
Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysisColin A Hutchison, Arthur R Bradwell, Mark Cook, et al.
Epilepsy & Behavior : E&B|August 27, 2021
Long-term mood, quality of life, and seizure freedom in intracranial EEG epilepsy surgeryOshi Swarup, Alexandra Waxmann, Jocelyn Chu, et al.
The Lancet. Haematology|March 16, 2019
High cutoff versus high-flux haemodialysis for myeloma cast nephropathy in patients receiving bortezomib-based chemotherapy (EuLITE): a phase 2 randomised controlled trialColin A Hutchison, Paul Cockwell, Veronica Moroz, et al.
Annals of Clinical and Translational Neurology|February 23, 2018
Is seizure frequency variance a predictable quantity?Daniel M Goldenholz, Shira R Goldenholz, Robert Moss, et al.
Pageof 16